218 related articles for article (PubMed ID: 30275053)
21. Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability.
Donada M; Bonin S; Nardon E; De Pellegrin A; Decorti G; Stanta G
J Cancer Res Clin Oncol; 2011 Feb; 137(2):201-10. PubMed ID: 20387074
[TBL] [Abstract][Full Text] [Related]
22. Constructing disease-specific gene networks using pair-wise relevance metric: application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements.
Jiang W; Li X; Rao S; Wang L; Du L; Li C; Wu C; Wang H; Wang Y; Yang B
BMC Syst Biol; 2008 Aug; 2():72. PubMed ID: 18691435
[TBL] [Abstract][Full Text] [Related]
23. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
[TBL] [Abstract][Full Text] [Related]
24. CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.
Shiovitz S; Bertagnolli MM; Renfro LA; Nam E; Foster NR; Dzieciatkowski S; Luo Y; Lao VV; Monnat RJ; Emond MJ; Maizels N; Niedzwiecki D; Goldberg RM; Saltz LB; Venook A; Warren RS; Grady WM;
Gastroenterology; 2014 Sep; 147(3):637-45. PubMed ID: 24859205
[TBL] [Abstract][Full Text] [Related]
25. Gene expression network analysis of lymph node involvement in colon cancer identifies AHSA2, CDK10, and CWC22 as possible prognostic markers.
Han SW; Ahn JY; Lee S; Noh YS; Jung HC; Lee MH; Park HJ; Chun HJ; Choi SJ; Kim ES; Lee JY
Sci Rep; 2020 Apr; 10(1):7170. PubMed ID: 32345988
[TBL] [Abstract][Full Text] [Related]
26. Co-expression Network Analysis Identified COL8A1 Is Associated with the Progression and Prognosis in Human Colon Adenocarcinoma.
Shang J; Wang F; Chen P; Wang X; Ding F; Liu S; Zhao Q
Dig Dis Sci; 2018 May; 63(5):1219-1228. PubMed ID: 29497907
[TBL] [Abstract][Full Text] [Related]
27. Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.
Sinicrope FA; Shi Q; Allegra CJ; Smyrk TC; Thibodeau SN; Goldberg RM; Meyers JP; Pogue-Geile KL; Yothers G; Sargent DJ; Alberts SR
JAMA Oncol; 2017 Apr; 3(4):472-480. PubMed ID: 28006055
[TBL] [Abstract][Full Text] [Related]
28. Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting.
Morris M; Platell C; McCaul K; Millward M; van Hazel G; Bayliss E; Trotter J; Ransom D; Iacopetta B
Int J Colorectal Dis; 2007 Aug; 22(8):887-95. PubMed ID: 17235506
[TBL] [Abstract][Full Text] [Related]
29. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
[TBL] [Abstract][Full Text] [Related]
30. Construction of ceRNA networks reveals differences between distal and proximal colon cancers.
Qian W; Feng Y; Li J; Peng W; Gu Q; Zhang Z; Ji D; Wang Q; Zhang D; Sun Y
Oncol Rep; 2019 May; 41(5):3027-3040. PubMed ID: 30896838
[TBL] [Abstract][Full Text] [Related]
31. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
Tie J; Cohen JD; Wang Y; Christie M; Simons K; Lee M; Wong R; Kosmider S; Ananda S; McKendrick J; Lee B; Cho JH; Faragher I; Jones IT; Ptak J; Schaeffer MJ; Silliman N; Dobbyn L; Li L; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
JAMA Oncol; 2019 Dec; 5(12):1710-1717. PubMed ID: 31621801
[TBL] [Abstract][Full Text] [Related]
32. Delivery of Adjuvant Oxaliplatin for Colon Cancer: Insights From Routine Clinical Practice.
Satkunam N; Wei X; Biagi JJ; Nanji S; Booth CM
J Natl Compr Canc Netw; 2016 Dec; 14(12):1548-1554. PubMed ID: 27956539
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer models.
Bracker TU; Sommer A; Fichtner I; Faus H; Haendler B; Hess-Stumpp H
Int J Oncol; 2009 Oct; 35(4):909-20. PubMed ID: 19724929
[TBL] [Abstract][Full Text] [Related]
34. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
[TBL] [Abstract][Full Text] [Related]
35. Specific microRNAs as novel biomarkers for combination chemotherapy resistance detection of colon adenocarcinoma.
Hu J; Xu Y; Cai S
Eur J Med Res; 2015 Dec; 20():95. PubMed ID: 26626874
[TBL] [Abstract][Full Text] [Related]
36. Prevention and treatment of colon cancer by peroral administration of HAMLET (human α-lactalbumin made lethal to tumour cells).
Puthia M; Storm P; Nadeem A; Hsiung S; Svanborg C
Gut; 2014 Jan; 63(1):131-42. PubMed ID: 23348960
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of location-specific hub genes related to the pathogenesis of colon cancer.
Shi C; Ding K; Li KZ; Long L; Li JL; Hu BL
Med Oncol; 2020 Aug; 37(9):77. PubMed ID: 32743717
[TBL] [Abstract][Full Text] [Related]
38. Prognostic relevance of Src activation in stage II-III colon cancer.
Martínez-Pérez J; Lopez-Calderero I; Saez C; Benavent M; Limon ML; Gonzalez-Exposito R; Soldevilla B; Riesco-Martínez MC; Salamanca J; Carnero A; Garcia-Carbonero R
Hum Pathol; 2017 Sep; 67():119-125. PubMed ID: 28601656
[TBL] [Abstract][Full Text] [Related]
39. Sex-Associated Gene Expression Alterations Correlate With Esophageal Cancer Survival.
Weygant N; Chang K; Jackson CS; Vega KJ
Clin Transl Gastroenterol; 2020 Dec; 12(1):e00281. PubMed ID: 33464731
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analyses of correlation and survival reveal informative lncRNA prognostic signatures in colon cancer.
Gao M; Guo Y; Xiao Y; Shang X
World J Surg Oncol; 2021 Apr; 19(1):104. PubMed ID: 33836755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]